Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04885504 · ClinicalTrials.gov registry record

Post COVID-19 Biorepository

A clinical trial of Coronavirus Infection, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT04885504 is a study of Coronavirus Infection that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 100 participants, below the 255-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04885504, a study of Coronavirus Infection, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.

Conditions Studied

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-02-08
Est. Completion 2026-07-15

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT04885504

The ClinicalTrials.gov registry entry for NCT04885504 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (61% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronavirus Infection appearing as the primary indexed condition, and to 0 interventions.

NCT04885504 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT04885504 about?

NCT04885504 is a clinical study titled "Post COVID-19 Biorepository". Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.

What is the current status of trial NCT04885504?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-02-08. Estimated completion is 2026-07-15.

What conditions does trial NCT04885504 study?

This clinical trial studies the following conditions: Coronavirus Infection.

Who is sponsoring clinical trial NCT04885504?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04885504 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronavirus Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.